|
|
| |
 |
Grants 2004 - 2005 |
|
| |
Center for the Study of Rural Vehicular Trauma
(Sponsor: Department of Transportation)
PI: Richard Gonzalez, MD
Award: $1,000,000.00 |
| |
Critical Care Family Assistance Program
(Sponsor: The Chest Foundation)
PI: Joseph LoCicero, III, MD
Award: $78,000.00 |
| |
Cerium Nitrate/Silver Sulfadiazine Cream vs Silver Sulfadiazine Cream Alone in the Treatment of Burn Patients (Sponsor: Synthes)
A Prospective, Multicenter, Double-Blind With In-House Blinding, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in Adults
PI: Arnold Luterman, MD
Co-Inv: Karen Frye, MD, D. Lynn Dyess, MD
Award: Per capita funding |
| |
A Phase III, Prospective, Comparative Evaluation of AQUACELL® Dressing and Silver Sulfadiazine in the Management of Partial Thickness Burns
(Sponsor: Convatec)
PI: Arnold Luterman, MD
Co-Inv: Karen Frye, MD, D. Lynn Dyess, MD
Award: Per capita funding |
| |
Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
(Sponsor: Mediwound )
PI: Luterman
Co-Inv: Karen Frye, MD, D. Lynn Dyess, MD
Award: Per capita funding |
| |
A Randomized, Serum Level Study Investigating the Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Patients with Various Refractory Malignancies
(Sponsor: Titan, Pharm.)
PI: John Boullier, MD
Award: Per capita funding |
| |
A Multicenter, Double-Blind, Randomized, Phase 3 Study to Compare the Safety and Efficacy of Intravenous Doripenem with that of Meropenem in Complicated Intra-abdominal Infections.
(Sponsor: Pennisula)
PI: Arnold Luterman, MD
Co-Inv: Joseph LoCicero, III, MD, Richard Gonzalez, MD, Charles Rodning, MD, Karen Frye, MD, D. Lynn Dyess, MD, Juvonda Hodge, MD
Award: Per capita funding |
| |
A Multicenter, Phase 3 Study to Confirm the Safety and Efficacy of Intravenous Doripenem in Complicated Lower Urinary Tract Infection or Pyelonephritis.
(Sponsor: Pennisula)
PI: John Boullier, MD
Co-Inv: Arnold Luterman, MD, Juvonda Hodge, MD
Award: Per capita funding |
| |
A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy And Safety of Epoetin Alfa in Critically Ill Subjects
(Sponsor: CareStat)
PI: Arnold Luterman, MD
Co-Inv: Joseph LoCicero, III, MD, Richard Gonzalez, MD, Charles Rodning, MD, Karen Frye, MD, D. Lynn Dyess, MD, Juvonda Hodge, MD
Award: Per capita funding |
| |
A Study to Evaluate the Safety and Efficacy of Fibrin Sealant with 4IU/ML Thrombin Vapor Heated, Solvent/Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
(Sponsor: Baxter)
PI: Arnold Luterman, MD
Co-Inv: Karen Frye, MD, D. Lynn Dyess, MD
Award: Per capita funding |
| |
A Multicenter, Open-label, Randomized Study to Compare the Safety and Efficacy of Once Daily Levofloxacin along with Once Daily Metronidazole Versus Piperacillin/tazobactam in the Treatment of Complicated Appendicitis
(Sponsor: Ortho-McNeil)
PI: Juvonda Hodge, MD
Co-Inv: Joseph LoCicero, III, MD, Richard Gonzalez, MD, Charles Rodning, MD, D. Lynn Dyess, MD, Arnold Luterman, MD
Award: Per capita funding |
| |
A Multicenter, Randomized, Controlled Trial Comparing The Safety And Effectiveness Of Surfaxin (Lucinactant) Delivered Via Bronchopulmonary Segmental Lavage To Standard Of Care In Patients With Acute Respiratory Distress Syndrome (ARDS). (Sponsor: Discovery Labs)
PI: Richard Gonzalez, MD
Co-Inv: Joseph LoCicero, III, MD, Charles Rodning, MD, D. Lynn Dyess, MD, Arnold Luterman, MD, Juvonda Hodge, MD
Award: Per capita funding |
| |
A Phase 3, Multicenter, Double-Blind, Randomized (3:1) Study Evaluating Tigecycline & Linezolid For The Treatment Of Selected Serious Infections In Subjects With Vancomycin-Resistant Enterococcus (VRE) And Evaluating Tigecycline & Vancomycin For The Treatment Of Selected Serious Infections In Subjects With Methicillin-Resistant Staphylococcus Aureus (MRSA)
(Sponsor: Wyeth)
PI: Luterman
Co-Inv: Juvonda Hodge, MD
Award: Per capita funding |
| |
A Phase 3, Open-Label, Noncomparative Study Of Tigecycline For The Treatment Of Subjects With Selected Serious Infections Due To Resistant Gram-Negative Organisms Such As Enterobacter Species, Acinetobacter Baumannii, And Klebsiella Pneumoniae
(Sponsor: Wyeth)
PI: Arnold Luterman, MD
Co-Inv: Joseph LoCicero, III, MD, Richard Gonzalez, MD, Charles Rodning, MD, D. Lynn Dyess, MD , Juvonda Hodge, MD
Award: Per capita funding |
| |
| |
LINKS |
| |
| New
IRB Initiatives |
| |
| Global
Research |
| |
| USA
Clinical Research |
| |
| |
|
|
| |
|
|
